life scienc tool diagnost
purr guid hold steadi fx
exceed estimate better revenu profit factor
line ad re-affirmed ep guidanc fx
importantli maintain organ top-line growth expect rais
ep reflect beat off-set primarili fx
pt move higher view
impress top-line companion strength meaning profit upsid
oper revenu match estim us also
line momentum companion anim vs estimate driven
parasiticid apoquel cytopoint abaxi us livestock vs
disappoint note distributor purchas pattern potenti
compar experi partial off-set strength poultri
ex fx also match view consider strength
companion vs estimate dermatolog simparica
abaxi partial off-set modest declin livestock vs estimate
asf japan divestitur gross margin improv notabl
bp bp plan admin expens declin bp
bp better plan contribut ebit margin expans bp
bp estim await cash flow balanc sheet data
share grind higher view momentum share
continu latest beat heroic companion anim oper growth
impress profit upsid guidanc maintain
primarili attribut fx headwind make monument
chang oper revenu assumpt focu call
demand trend across companion anim livestock dairi asf top
product atop dermat simparica trend competit updat
draxxin/ceftiofur abaxi integration/contribut pipelin updat
capit deploy prioriti risk includ shift fundament demand
slower traction new products/pipelin
valuat metric
number share
price month
 close
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
global leader develop anim health
therapeut livestock companion anim diversifi
portfolio product line directli market countri
industri largest sale forc
price may rate outperform target price analyst erin wright
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
 close
blue sky scenario assum meaning profit
contribut oper effici initi greater
expect adopt futur recent launch product
substanti share gain well stronger anticip growth
anim health fundament
grey sky scenario assum lower expect
ramp profit weaker traction new product potenti
distribut manufactur disrupt fx macroeconom
headwind weak companion product anim
compani mention price
